FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elisabetta Loggi

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Liver Transplantation

Concepts & Ideas

Physiology

Genotype

Co-author Network

Publications

TOP 3
Elisabetta Loggi; Arianna Martello Panno; Alessandra Scuteri; Mauro Bernardi; Carmela Cursaro; Giuliano Furlini; Claudio Galli; Silvia Galli; Elena Grandini; Pietro Andreone
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C.
Lorenzo Micco; Arianna Martello Panno; Dimitra Peppa; Anna Schurich; Pietro Andreone; Mauro Bernardi; Florian Bihl; Christian Brander; Carmela Cursaro; Lucy Jefferson; Elisabetta Loggi; Mala K Maini
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
Paola Fisicaro; Tiziana Giuberti; Elisabetta Loggi; Marco Massari; Gabriele Missale; Lara Ravanetti; Simona Urbani; Caterina Valdatta; Carmen Vandelli; Pietro Andreone; Albertina Cavalli; Carlo Ferrari
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elisabetta Loggi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elisabetta Loggi; Arianna Martello Panno; Alessandra Scuteri; Mauro Bernardi; Carmela Cursaro; Giuliano Furlini; Claudio Galli; Silvia Galli; Elena Grandini; Pietro Andreone
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013;56(3):207-11.
2013: Lorenzo Micco; Arianna Martello Panno; Dimitra Peppa; Anna Schurich; Pietro Andreone; Mauro Bernardi; Florian Bihl; Christian Brander; Carmela Cursaro; Lucy Jefferson; Elisabetta Loggi; Mala K Maini
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
Journal of hepatology 2013;58(2):225-33.
2012: Paola Fisicaro; Tiziana Giuberti; Elisabetta Loggi; Marco Massari; Gabriele Missale; Lara Ravanetti; Simona Urbani; Caterina Valdatta; Carmen Vandelli; Pietro Andreone; Albertina Cavalli; Carlo Ferrari
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Gastroenterology 2012;143(6):1576-1585.e4.
2012: Amalia Penna; Simona Schivazappa; Mauro Viganò; Arianna Alfieri; Diana Canetti; Massimo Colombo; Tiziana Giuberti; Diletta Laccabue; Pietro Lampertico; Irene Libri; Elisabetta Loggi; Gabriele Missale; Cristina Mori; Carlo Ferrari
Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis.
Journal of hepatology 2012;56(6):1239-46.
2012: Elisabetta Loggi; Lorenzo Micco; Antonio Daniele Pinna; Alessandro Nanni Costa; Mauro Bernardi; Florian Bihl; Andrea Bontadini; Christian Brander; Alessandro Cucchetti; Giorgio Ercolani; Stefano Gitto; Gian Luca Grazi; Paolo Grossi; Pietro Andreone
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
Journal of hepatology 2012;56(3):579-85.
2011: Annagiulia Gramenzi; Elisabetta Loggi; Lorenzo Micco; Mauro Bernardi; Carmela Cursaro; S Fiorino; Giuliano Furlini; C Galli; Silvia Galli; S Gitto; Pietro Andreone
Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients.
Journal of viral hepatitis 2011;18(10):e468-74.
2011: Sirio Fiorino; Fabio Conti; Annagiulia Gramenzi; Elisabetta Loggi; Carmela Cursaro; Roberto Di Donato; Lorenzo Micco; Stefano Gitto; Andrea Cuppini; Mauro Bernardi; Pietro Andreone
Vitamins in the treatment of chronic viral hepatitis.
The British journal of nutrition 2011;105(7):982-9.
2010: E Grandini; F Cannoletta; A Scuteri; C Fortini; Elisabetta Loggi; Carmela Cursaro; A Riili; R Di Donato; Annagiulia Gramenzi; Mauro Bernardi; Pietro Andreone
Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis C.
Annals of the New York Academy of Sciences 2010;1194():147-52.
2010: Paola Fisicaro; Caterina Valdatta; Marco Massari; Elisabetta Loggi; Elisabetta Biasini; Luca Sacchelli; Maria Cristina Cavallo; Enrico M Silini; Pietro Andreone; Gabriele Missale; Carlo Ferrari
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
Gastroenterology 2010;138(2):682-93, 693.e1-4.
2009: Annagiulia Gramenzi; Carmela Cursaro; Marzia Margotti; Clara Balsano; Alessandra Spaziani; Simona Anticoli; Elisabetta Loggi; Maddalena Salerno; Silvia Galli; Giuliano Furlini; Mauro Bernardi; Pietro Andreone
Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study.
World journal of gastroenterology : WJG 2009;15(47):5946-52.
2009: Elisabetta Loggi; Florian Bihl; John V Chisholm; Maurizio Biselli; Andrea Bontadini; Giovanni Vitale; Giorgio Ercolani; Gian Luca Grazi; Antonio Daniele Pinna; Mauro Bernardi; Christian Brander; Pietro Andreone
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft.
Journal of hepatology 2009;50(3):625-30.
2009: Lorenzo Micco; Anna Riili; Giovanni Vitale; Mauro Bernardi; Carmela Cursaro; S Fiorino; Elisabetta Loggi; Stefania Lorenzini; Pietro Andreone
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report.
BMJ case reports 2009;2009():.
2008: Anthony Tan; Elisabetta Loggi; Carolina Boni; Adeline Chia; Adam J Gehring; Konduru S R Sastry; Vera Goh; Paola Fisicaro; Pietro Andreone; Christian Brander; Seng Gee Lim; Carlo Ferrari; Florian Bihl; Antonio Bertoletti
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.
Journal of virology 2008;82(22):10986-97.
2008: Elisabetta Loggi; Annagiulia Gramenzi; Marzia Margotti; Carmela Cursaro; Silvia Galli; G Vitale; E Grandini; A Scuteri; R Vukotic; Pietro Andreone; Mauro Bernardi
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
Journal of viral hepatitis 2008;15(6):442-8.
2008: Florian Bihl; Elisabetta Loggi; John V Chisholm; Maurizio Biselli; Maria C Morelli; Carmela Cursaro; Norah A Terrault; Mauro Bernardi; Antonio Bertoletti; Pietro Andreone; Christian Brander
Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(4):478-85.
2007: Olivier Gasser; Florian K Bihl; Marcel Wolbers; Elisabetta Loggi; Ingrid Steffen; Hans Hirsch; Huldrych Günthard; Bruce D Walker; Christian Brander; Manuel Battegay; Christoph Hess
HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts.
PLoS medicine 2007;4(3):e96.
2007: Maria Stella De Mitri; Giulia Morsica; Romina Cassini; Sabrina Bagaglio; Pietro Andreone; G Bianchi; Elisabetta Loggi; Mauro Bernardi
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses.
Archives of virology 2007;152(2):395-404.
2006: Roberto M Lemoli; Lucia Catani; Simona Talarico; Elisabetta Loggi; Annagiulia Gramenzi; Umberto Baccarani; Miriam Fogli; Gian Luca Grazi; Michela Aluigi; Giulia Marzocchi; Mauro Bernardi; Antonio Pinna; Fabrizio Bresadola; Michele Baccarani; Pietro Andreone
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.
Stem cells (Dayton, Ohio) 2006;24(12):2817-25.
2006: Annagiulia Gramenzi; Fabio Caputo; Maurizio Biselli; F Kuria; Elisabetta Loggi; Pietro Andreone; Mauro Bernardi
Review article: alcoholic liver disease--pathophysiological aspects and risk factors.
Alimentary pharmacology & therapeutics 2006;24(8):1151-61.
2006: Maria Stella De Mitri; Romina Cassini; Giulia Morsica; Sabrina Bagaglio; Pietro Andreone; Elisabetta Loggi; Paolo Muratori; Mauro Bernardi
Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
Journal of viral hepatitis 2006;13(9):574-81.
2006: Maurizio Biselli; Pietro Andreone; Annagiulia Gramenzi; Stefania Lorenzini; Elisabetta Loggi; Francesca Bonvicini; Carmela Cursaro; Mauro Bernardi
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(1):27-32.
2005: Annagiulia Gramenzi; Pietro Andreone; Elisabetta Loggi; Federico Foschi; Carmela Cursaro; Marzia Margotti; Maurizio Biselli; Mauro Bernardi
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.
Journal of viral hepatitis 2005;12(5):525-30.
2005: Federico Foschi; Franco Trevisani; Elisabetta Loggi; Monica Parazza; Cristina Melotti; Enrico Bedeschi; Lorenza Mingazzini; Federica Mirici Cappa; Matteo Cescon; Pietro Andreone; Gian Luca Grazi; Giuseppe Francesco Stefanini; Mauro Bernardi
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophil granulocytes in patients with liver cirrhosis.
International archives of allergy and immunology 2005;137(3):258-62.
2004: Pietro Andreone; Annagiulia Gramenzi; Elisabetta Loggi; Laura Favarelli; Carmela Cursaro; Marzia Margotti; Maurizio Biselli; Stefania Lorenzini; Mauro Bernardi
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.
Cytokine 2004;26(3):95-101.
2004: Pietro Andreone; Annagiulia Gramenzi; Carmela Cursaro; Francesco Felline; Elisabetta Loggi; Antonia D'Errico; M Spinosa; Stefania Lorenzini; Maurizio Biselli; Mauro Bernardi
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial.
Journal of viral hepatitis 2004;11(1):69-73.
2003: Pietro Andreone; Annagiulia Gramenzi; Carmela Cursaro; Maurizio Biselli; Stefania Lorenzini; Elisabetta Loggi; Francesco Felline; S Fiorino; Loriana Di Giammarino; F Porzio; Silvia Galli; Mauro Bernardi
Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial.
Journal of viral hepatitis 2003;10(4):306-9.
2003: S Lodrini; Sabrina Bagaglio; Filippo Canducci; Maria Stella De Mitri; Pietro Andreone; Elisabetta Loggi; Adriano Lazzarin; M Clementi; Giulia Morsica
Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Journal of biological regulators and homeostatic agents 2003;17(2):198-204.
2003: Sabrina Bagaglio; R Bruno; S Lodrini; Maria Stella De Mitri; Pietro Andreone; Elisabetta Loggi; Laura Galli; Adriano Lazzarin; Giulia Morsica
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.
Journal of biological regulators and homeostatic agents 2003;17(2):153-61.
2002: Franco Trevisani; Elena Castelli; Federico Foschi; Monica Parazza; Elisabetta Loggi; M Bertelli; C Melotti; Marco Domenicali; G Zoli; Mauro Bernardi
Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome.
Gut 2002;50(5):707-12.